These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3891023)

  • 1. Variables determining the amount of microbial contamination on cadaveric allograft skin used as a biological wound dressing.
    May SR; Wainwright JF; DeClement FA
    Burns Incl Therm Inj; 1985 Apr; 11(4):242-51. PubMed ID: 3891023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sampling in the detection of microbial contamination on cadaveric allograft skin used as a biological wound dressing.
    May SR; Wainwright JF; DeClement FA
    Burns Incl Therm Inj; 1985 Oct; 12(1):36-48. PubMed ID: 3933768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis.
    Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S
    Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial contamination of skin used as a biological dressing. A potential hazard.
    Monafo WW; Tandon SN; Bradley RE; Condict C
    JAMA; 1976 Mar; 235(12):1248-9. PubMed ID: 765519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of Biobrane™ and cadaveric allograft for temporizing the acute burn wound: Cost and procedural time.
    Austin RE; Merchant N; Shahrokhi S; Jeschke MG
    Burns; 2015 Jun; 41(4):749-53. PubMed ID: 25458501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can contamination of a patient's allograft be traced back to the allograft donor?
    Neely AN; Plessinger RT; Stamper B; Kagan RJ
    J Burn Care Res; 2008; 29(1):73-6. PubMed ID: 18182900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary skin substitutes for burn patients: a nursing perspective.
    Nowicki CR; Sprenger CK
    J Burn Care Rehabil; 1988; 9(2):209-15. PubMed ID: 3283136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bacteria on transplantable allograft skin after preparation with chlorhexidine gluconate, povidone-iodine, and isopropanol.
    May SR; Roberts DP; DeClement FA; Still JM
    J Burn Care Rehabil; 1991; 12(3):224-8. PubMed ID: 1885638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procurement and transplantation of colonized cadaver skin.
    White MJ; Whalen JD; Gould JA; Brown GL; Polk HC
    Am Surg; 1991 Jun; 57(6):402-7. PubMed ID: 2048856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amniotic membrane: a versatile wound dressing.
    Gruss JS; Jirsch DW
    Can Med Assoc J; 1978 May; 118(10):1237-46. PubMed ID: 647542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving practice of the Helsinki Skin Bank.
    Lindford AJ; Frey I; Vuola J; Koljonen V
    Int Wound J; 2010 Aug; 7(4):277-81. PubMed ID: 20492012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.
    Hansbrough JF; Mozingo DW; Kealey GP; Davis M; Gidner A; Gentzkow GD
    J Burn Care Rehabil; 1997; 18(1 Pt 1):43-51. PubMed ID: 9063787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to improve donor skin availability: Pragmatic procedures to minimize the discard rate of cryopreserved allografts in skin banking.
    Germain N; Hatzfeld AS; Pasquesoone L; Danze PM; Guerreschi P; Sendid B; Gaillot O; Marchetti P
    Burns; 2021 Mar; 47(2):387-396. PubMed ID: 32788056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors.
    Pianigiani E; Ierardi F; Cuciti C; Brignali S; Oggioni M; Fimiani M
    Burns; 2010 May; 36(3):347-51. PubMed ID: 19616385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadaveric allograft discards as a result of positive skin cultures.
    Obeng MK; McCauley RL; Barnett JR; Heggers JP; Sheridan K; Schutzler SS
    Burns; 2001 May; 27(3):267-71. PubMed ID: 11311520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised clinical trial comparing a hydrocolloid-derived dressing and glycerol preserved allograft skin in the management of partial thickness burns.
    Vloemans AF; Soesman AM; Suijker M; Kreis RW; Middelkoop E
    Burns; 2003 Nov; 29(7):702-10. PubMed ID: 14556729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of human deceased donor skin allograft in burn care.
    Leon-Villapalos J; Eldardiri M; Dziewulski P
    Cell Tissue Bank; 2010 Feb; 11(1):99-104. PubMed ID: 20077178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.
    Purdue GF; Hunt JL; Still JM; Law EJ; Herndon DN; Goldfarb IW; Schiller WR; Hansbrough JF; Hickerson WL; Himel HN; Kealey GP; Twomey J; Missavage AE; Solem LD; Davis M; Totoritis M; Gentzkow GD
    J Burn Care Rehabil; 1997; 18(1 Pt 1):52-7. PubMed ID: 9063788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing.
    Gajiwala K; Gajiwala AL
    Cell Tissue Bank; 2004; 5(2):73-80. PubMed ID: 15241002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological evaluation of glycerolized cadaveric donor skin.
    van Baare J; Ligtvoet EE; Middelkoop E
    Transplantation; 1998 Apr; 65(7):966-70. PubMed ID: 9565102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.